
Opus Genetics, Inc.
Opus Genetics, Inc. (IRD)
WebsitePrice
Market cap
Next catalystExpected Q4 2026OPGx-RDH12 — planned Phase 1/2 dosing · Trial initiationCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved